The topographical distribution of tissue injury in benign MS: a 3T multiparametric MRI study

Antonia Ceccarelli1, Maria A Rocca, Elisabetta Pagani

  • 1Neuroimaging Research Unit, Scientific Institute and University Ospedale San Raffaele, Milan, Italy.

Neuroimage
|December 25, 2007
PubMed

Insights

Benign multiple sclerosis (MS) and relapsing-remitting MS (RRMS) patients show similar brain damage extent but differ in white matter lesion distribution. Benign MS primarily affects posterior brain regions, unlike RRMS.

Area of Science:

  • Neuroimaging
  • Neurology
  • Radiology

Background:

  • Multiple Sclerosis (MS) is a chronic neurological disease.
  • Distinguishing between benign MS (BMS) and relapsing-remitting MS (RRMS) is crucial for prognosis and treatment.
  • Understanding the topographical distribution of brain damage in different MS subtypes is essential.

Purpose of the Study:

  • To compare the global and regional distribution of white matter (WM) and gray matter (GM) damage between BMS and RRMS patients.
  • To investigate differences in T2-visible lesion location between BMS and RRMS.
  • To correlate brain structural changes with clinical status.

Main Methods:

  • Diffusion Tensor (DT) MRI and T2-visible lesion mapping were used.
  • Global and regional WM and GM volumes and metrics were analyzed.
  • Comparisons were made between BMS patients, RRMS patients, and healthy controls.

Main Results:

  • BMS and RRMS patients showed no significant differences in global brain volumes or overall DT-MRI metrics.
  • Both MS groups exhibited bilateral thalamic loss and reduced WM fractional anisotropy (FA) in specific brain regions compared to controls.
  • T2-lesion distribution differed, with BMS showing posterior lesions and RRMS involving frontal lobe regions.

Conclusions:

  • BMS and RRMS patients differ in the topographical distribution of WM damage, not the overall extent of brain structural changes.
  • The less pronounced frontal lobe WM involvement in BMS may correlate with their favorable clinical status.
  • These findings highlight the importance of lesion location in understanding MS subtypes.